Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: LEADING PHARMA LLC

Referral inspection · Health discipline

On , OSHA opened a referral health inspection of LEADING PHARMA LLC in 3 OAK ROAD, FAIRFIELD, NJ 07004 (NAICS 325412). OSHA activity number 343842563.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Leading Pharma LLC — free Get an email when a new federal OSHA severe-injury report for Leading Pharma LLC is published. One employer, no account, unsubscribe in one click.
Establishment
LEADING PHARMA LLC
Site address
3 OAK ROAD
City
FAIRFIELD
State
NJ
ZIP
07004
Mailing
3 OAK ROAD, FAIRFIELD, NJ 07004
Inspection type
Referral (C)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
B
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
Employees
155
Ownership type
A

6 citations on file for this inspection.

1910.134 C01

Serious Gravity 5 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $8,525 · Current $6,500 Reduced
29 CFR 1910.134(c)(1): A written respiratory protection program that included the provisions in 29 CFR 1910.134(c)(1)(i) - (ix) with worksite specific procedures was not established and implemented for required respirator use:     a) 3 Oak Rd., Fairfield, NJ    The employer did not establish and implement a written respiratory protection programs for employees required to wear half mask negative pressure and filtering face piece respirators during production of pharmaceuticals.      Violation occurred on or about 3/12/19 and 4/30/19
Recent events (2)
  • — I (S) $6500
  • — Z (S) $8525

1910.134 E01

Serious Gravity 5 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $0 · Current $0
29 CFR 1910.134(e)(1): The employer did not provide a medical evaluation to determine the employee's ability to use a respirator, before the employee was fit tested or required to use the respirator in the workplace:  a) 3 Oak Rd., Fairfield, NJ  The employer did not provide a medical evaluation for employees required to wear half mask negative pressure and filtering face piece respirators during production of pharmaceuticals.   Violation occurred on or about 3/12/19 and 4/30/19
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

1910.134 F02

Serious Gravity 5 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $0 · Current $0
29 CFR 1910.134(f)(2): Employee(s) using tight-fitting facepiece respirators were not fit tested prior to initial use of the respirator:  a) 3 Oak Rd., Fairfield, NJ  The employer did not provide fit tests prior to initial use for employees required to wear half mask negative pressure and filtering face piece respirators during production of pharmaceuticals.   Violation occurred on or about 3/12/19 and 4/30/19
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

1910.134 K01

Serious Gravity 5 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $0 · Current $0
29 CFR 1910.134(k)(1): The employer did not provide effective training that covered the required elements in 1910.134(k)(1)(i) through 1910.134(k)(1)(vii):  a) 3 Oak Rd., Fairfield, NJ  The employer did not provide training in the fit, usage and maintenance of respirators to employees required to wear half mask negative pressure and filtering face piece respirators during production of pharmaceuticals.   Violation occurred on or about 3/12/19 and 4/30/19
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

1910.1200 E01

Serious Gravity 10 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $11,934 · Current $6,500 Reduced
29 CFR 1910.1200(e)(1): The employer did not implement their written hazard communication program which describes how the criteria specified in 29 CFR 1910.1200(f), (g), and (h) will be met:     a)  3 Oak Rd., Fairfield, NJ    The employer did not implement a written hazard communication program for workers exposed to hazardous chemicals during production of pharmaceuticals to include but not limited to Lorazepam and Furosemide, which may cause cancer and genetic defects.      Condition observed on or about 4/30/19
Recent events (2)
  • — I (S) $6500
  • — Z (S) $11934

1910.1200 H01

Serious Gravity 10 1 instance 30 exposed
Issued
Sep 4, 2019
Abate by
Oct 23, 2019
Penalty
Initial $0 · Current $0
29 CFR 1910.1200(h)(1): Employees were not provided effective information and training on hazardous chemicals in their work area at the time of their initial assignment and whenever a new hazard that the employees had not been previously trained about was introduced into their work area:  a)  3 Oak Rd., Fairfield, NJ  The employer did not provide employees with effective information on hazardous chemicals, including but not limited to Lorazepam and Furosemide, which may cause cancer and genetic defects.    Condition observed on or about 4/30/19
Recent events (2)
  • — I (S) $0
  • — Z (S) $0

View Leading Pharma LLC's full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 343842563.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.